Delcath Sys Inc - Ordinary Shares

(DCTH)

By |

Profile

Delcath Systems Inc is a specialty pharmaceutical and medical device company. It is engaged in the development and commercialization of CHEMOSAT/Melphalan/HDS. The company focuses on the treatment of primary and metastatic liver cancers.

Contact Information

Website: www.delcath.com
Email: investorrelations@delcath.com
Main Phone: +1 212 489-2100
Address: 1633 Broadway
Address 2: 22nd Floor, Suite C
State: NY
City / Town: New York
Country: USA
Postal Code: 10019

Issuer Information

Exchange: OTCQB
CEO: Jennifer K. Simpson
Employees: 46
NAICS: Medical Laboratories (621511)
$ 2.55 $ 0.10 (4.08%)
Last Price 2.55 Change $ 0.10 Change % 4.08 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open 2.55 High 2.55 Low 2.28 Prev Close 2.45
Last Trade Volume 4,233 52 Wk Hi 42,000.00 52 Wk Low 1.22
Market Cap 2.3 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 896,994.00 EPS (TTM) 7,825.66 PE Ratio 0.00 Exchange OTCQB
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
Marco Taglietti 1,000
Marco Taglietti 1,000
Marco Taglietti 1,000
Marco Taglietti 1,000
Roger G. Stoll 1,000
Marco Taglietti 1,000
Marco Taglietti 1,000
Marco Taglietti 1,000
Laura A. Philips 1,000
William D. Rueckert 1,000
Last 10 Sell Shares
Krishna Kandarpa 1,000
Robert B. Ladd 1,000
Robert B. Ladd 1,000
Robert B. Ladd 1,000
Robert B. Ladd 1,000
Robert B. Ladd 1,000
Robert B. Ladd 1,000
Robert B. Ladd 1,000
Robert B. Ladd 1,000
Robert B. Ladd 1,000
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 1.3 1.3 1.3 1.3
Low Target Price Estimate 1.3 1.3 1.3 1.3
Mean Target Price Estimate 1.3 1.3 1.3 1.3
Standard Deviation 0 0 0 0
Date of Most Recent Estimate 08/01/13 08/01/13 08/01/13 08/01/13
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 1
Mean Rec. 0 0 0 5